Kaulen, Leon D. http://orcid.org/0000-0002-5937-3376
Denisova, Evgeniya http://orcid.org/0000-0001-6258-8055
Hinz, Felix
Hai, Ling http://orcid.org/0000-0001-8719-2727
Friedel, Dennis
Henegariu, Octavian http://orcid.org/0000-0002-8971-1049
Hoffmann, Dirk C. http://orcid.org/0000-0003-1370-1933
Ito, Jakob
Kourtesakis, Alexandros http://orcid.org/0000-0002-7894-9131
Lehnert, Pascal
Doubrovinskaia, Sofia http://orcid.org/0000-0003-4470-8396
Karschnia, Philipp http://orcid.org/0000-0002-1254-5310
von Baumgarten, Louisa http://orcid.org/0000-0002-6634-0927
Kessler, Tobias http://orcid.org/0000-0001-8350-7074
Baehring, Joachim M. http://orcid.org/0000-0001-7755-6793
Brors, Benedikt http://orcid.org/0000-0001-5940-3101
Sahm, Felix http://orcid.org/0000-0001-5441-1962
Wick, Wolfgang http://orcid.org/0000-0002-6171-634X
Funding for this research was provided by:
Universitätsklinikum Heidelberg
Article History
Received: 28 May 2023
Revised: 10 July 2023
Accepted: 11 July 2023
First Online: 26 July 2023
Declarations
:
: Dr. Kaulen reports no disclosures. Dr. Denisova reports no disclosures. Dr. Hinz reports no disclosures. Ms. Hai reports no disclosures. Mr. Friedel reports no disclosures. Dr. Henegariu reports no disclosures. Mr. Hoffmann reports no disclosures. Mr. Ito reports no disclosures. Mr. Kourtesakis reports no disclosures. Mr. Lehnert reports no disclosures. Dr. Doubrovinskaia reports no disclosures. Dr. Karschnia reports no disclosures. Dr. von Baumgarten reports no disclosures. Dr. Kessler reports no disclosures. Dr. Baehring reports no disclosures. Dr. Brors reports no disclosures. Dr. Sahm reports honoraria from Illumina, Agilent and Bayer, patents on methylation-based classification managed by DKFZ, and being cofounder and shareholder of Heidelberg Epignostix GmbH. Dr. Wick reports support for clinical trials from Apogenix, Pfizer, Roche and Vaximm as well as honoraria for advice from Astra Zeneca, Enterome, MSD, Roche, Servier and Vaximm paid to the Medical Faculty.